News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
714,646 Results
Type
Article (42331)
Company Profile (436)
Press Release (671879)
Multimedia
Podcasts (78)
Webinars (13)
Section
Business (208751)
Career Advice (2022)
Deals (36010)
Drug Delivery (104)
Drug Development (83582)
Employer Resources (173)
FDA (16433)
Job Trends (15099)
News (352818)
Policy (33084)
Tag
Academia (2644)
Accelerated approval (6)
Adcomms (24)
Allergies (87)
Alliances (50963)
ALS (94)
Alzheimer's disease (1431)
Antibody-drug conjugate (ADC) (139)
Approvals (16424)
Artificial intelligence (268)
Autoimmune disease (25)
Automation (16)
Bankruptcy (372)
Best Places to Work (11841)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (330)
Bladder cancer (82)
Brain cancer (27)
Breast cancer (287)
Cancer (2316)
Cardiovascular disease (185)
Career advice (1690)
Career pathing (30)
CAR-T (157)
Cell therapy (444)
Cervical cancer (19)
Clinical research (67781)
Collaboration (877)
Compensation (532)
Complete response letters (24)
COVID-19 (2648)
CRISPR (45)
C-suite (252)
Cystic fibrosis (105)
Data (2232)
Decentralized trials (2)
Denatured (28)
Depression (50)
Diabetes (275)
Diagnostics (6427)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (127)
Drug pricing (107)
Drug shortages (26)
Duchenne muscular dystrophy (100)
Earnings (87849)
Editorial (40)
Employer branding (21)
Employer resources (147)
Events (115949)
Executive appointments (743)
FDA (17701)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (783)
Gene editing (113)
Generative AI (20)
Gene therapy (328)
GLP-1 (747)
Government (4503)
Grass and pollen (4)
Guidances (59)
Healthcare (19147)
Huntington's disease (24)
IgA nephropathy (30)
Immunology and inflammation (130)
Indications (30)
Infectious disease (2793)
Inflammatory bowel disease (143)
Inflation Reduction Act (11)
Influenza (52)
Intellectual property (98)
Interviews (311)
IPO (16790)
IRA (43)
Job creations (3702)
Job search strategy (1435)
Kidney cancer (10)
Labor market (38)
Layoffs (496)
Leadership (18)
Legal (7986)
Liver cancer (76)
Lung cancer (328)
Lymphoma (155)
Machine learning (7)
Management (58)
Manufacturing (313)
MASH (69)
Medical device (13526)
Medtech (13531)
Mergers & acquisitions (19759)
Metabolic disorders (718)
Multiple sclerosis (82)
NASH (19)
Neurodegenerative disease (102)
Neuropsychiatric disorders (33)
Neuroscience (2002)
NextGen: Class of 2025 (6755)
Non-profit (4551)
Now hiring (39)
Obesity (385)
Opinion (223)
Ovarian cancer (77)
Pain (89)
Pancreatic cancer (84)
Parkinson's disease (155)
Partnered (21)
Patents (236)
Patient recruitment (111)
Peanut (47)
People (58682)
Pharmaceutical (86)
Pharmacy benefit managers (19)
Phase I (21298)
Phase II (29908)
Phase III (22115)
Pipeline (1209)
Policy (146)
Postmarket research (2601)
Preclinical (9138)
Press Release (67)
Prostate cancer (110)
Psychedelics (37)
Radiopharmaceuticals (263)
Rare diseases (404)
Real estate (6015)
Recruiting (66)
Regulatory (22739)
Reports (46)
Research institute (2416)
Resumes & cover letters (351)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (76)
Series A (139)
Series B (90)
Service/supplier (11)
Sickle cell disease (57)
Special edition (17)
Spinal muscular atrophy (152)
Sponsored (30)
Startups (3762)
State (2)
Stomach cancer (14)
Supply chain (69)
Tariffs (39)
The Weekly (48)
Vaccines (705)
Venture capitalists (43)
Weight loss (255)
Women's health (37)
Worklife (17)
Date
Today (177)
Last 7 days (889)
Last 30 days (2698)
Last 365 days (33835)
2025 (10903)
2024 (36301)
2023 (41015)
2022 (52278)
2021 (56767)
2020 (54923)
2019 (47421)
2018 (35699)
2017 (33024)
2016 (32347)
2015 (38396)
2014 (32186)
2013 (27111)
2012 (29221)
2011 (29864)
2010 (27992)
Location
Africa (736)
Alabama (58)
Alaska (7)
Arizona (239)
Arkansas (14)
Asia (39257)
Australia (6532)
California (6240)
Canada (2022)
China (533)
Colorado (272)
Connecticut (286)
Delaware (149)
Europe (85810)
Florida (911)
Georgia (206)
Idaho (57)
Illinois (553)
India (25)
Indiana (310)
Iowa (12)
Japan (163)
Kansas (107)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (908)
Massachusetts (4741)
Michigan (221)
Minnesota (397)
Mississippi (2)
Missouri (82)
Montana (29)
Nebraska (25)
Nevada (63)
New Hampshire (67)
New Jersey (1757)
New Mexico (30)
New York (1761)
North Carolina (1033)
North Dakota (8)
Northern California (2699)
Ohio (206)
Oklahoma (14)
Oregon (38)
Pennsylvania (1389)
Puerto Rico (12)
Rhode Island (34)
South America (1110)
South Carolina (22)
South Dakota (1)
Southern California (2330)
Tennessee (101)
Texas (924)
United States (23638)
Utah (183)
Virginia (149)
Washington D.C. (63)
Washington State (574)
West Virginia (3)
Wisconsin (55)
714,646 Results for "seismic therapeutic inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Seismic Therapeutic Appoints Brendan St. Amant as General Counsel
Seismic Therapeutic, Inc today announced the appointment of Brendan St. Amant as General Counsel and a member of the company’s leadership team.
June 25, 2024
·
2 min read
Genetown
Seismic Therapeutic to Participate in Upcoming June Investor Conferences
Seismic Therapeutic, Inc today announced that company management will participate in the following June investor conferences.
May 29, 2024
·
1 min read
Genetown
Seismic Therapeutic Announces Participation at Multiple Upcoming Scientific Conferences in June 2024
Seismic Therapeutic, Inc today announced that the company will participate in three upcoming scientific conferences.
June 4, 2024
·
3 min read
Press Releases
Seismic Therapeutic Presents Preclinical Data on S-8484, Its Novel IgE Protease, for Treatment of Allergic Diseases
February 28, 2025
·
5 min read
Press Releases
Seismic Therapeutic Doses First Cohort in Phase 1 Clinical Trial of S-4321, a Novel Bifunctional Antibody that Agonizes PD-1 and FcγRIIb Inhibitory Receptors for the Treatment of Autoimmune Disease
April 10, 2025
·
4 min read
Press Releases
Seismic Therapeutic Doses First Cohort in Phase 1 Clinical Trial of S‑1117, a Novel Pan‑IgG Protease Therapy for Antibody-Mediated Diseases
March 12, 2025
·
3 min read
Press Releases
Seismic Therapeutic to Participate in Upcoming Investor Conferences
November 7, 2024
·
1 min read
Genetown
Seismic Therapeutic Announces Participation at Multiple Upcoming Scientific Conferences in April and May 2024
Seismic Therapeutic, Inc today announced that the company will participate in four upcoming scientific conferences, presenting the company’s emerging pipeline of novel therapeutics to treat rare and prevalent autoimmune diseases.
April 9, 2024
·
4 min read
Press Releases
Seismic Therapeutic Announces Presentations at Upcoming Scientific and Medical Conferences
November 5, 2024
·
3 min read
Genetown
Seismic Therapeutic to Present Preclinical Data for Novel Immunoglobulin Sculpting Enzyme at AAN Annual Meeting
Seismic Therapeutic, Inc today announced that the company will present preclinical data for its pan-immunoglobulin G (IgG) sculpting enzyme candidate, S-1117, at the American Academy of Neurology (AAN) annual meeting taking place on April 13-18 in Denver.
March 8, 2024
·
1 min read
1 of 71,465
Next
